CD40 and diabetic retinopathy: Furthermore, advanced glycation end products (AGEs) upregulate CD40 and potentiate CD40-CD154 signaling in retinal cells, which drives pro-inflammatory responses critical to the pathogenesis of diabetic retinopathy, a condition characterized by neurovascular degeneration (22).